Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): Results of the European Working Party

Blood

Volumn 96, Issue 4, 2000, Pages 1297-1308

  Grimwade, D ^a   Biondi, A ^a   Mozziconacci, M J ^a   Hagemeijer, A ^a   Berger, R ^a   Neat, M ^a   Howe, K ^a   Dastugue, N ^a   Jansen, J ^a   Radford Weiss, I ^a   Lo Coco, F ^a   Lessard, M ^a   Hernandez, J M ^a   Delabesse, E ^a   Head, D ^a   Liso, V ^a   Sainty, D ^a   Flandrin, G ^a   Solomon, E ^a   Birg, F ^a   Lafage Pochitaloff, M ^a   more..

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOID;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHROMOSOME ABERRATION; EUROPE; FEMALE; FUSION GENE; GENE INSERTION; GENE LOCATION; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENE REARRANGEMENT; GENETIC MARKERS; HUMANS; KARYOTYPING; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; TRANSLOCATION, GENETIC;

EID: 0034663029     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. A new morphological classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF-RARA rearrangements
2. Reassessing the hemostatic disorder associated with acute promyelocytic leukemia
3. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia
4. All-trans retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia
5. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients
6. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
7. Acute promyelocytic leukemia: Biology and treatment
8. All-trans-retinoic acid in acute promyelocytic leukemia
9. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups
10. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia
11. Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: Result of the randomized MRC trial
12. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia
13. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage
14. Overexpression of retinoic acid receptor α suppresses myeloid cell differentiation at the promyelocyte stage
15. Impaired granulocytic differentiation in vitro in hematopoietic cells lacking retinoic acid receptors α1 and γ
16. Role of PML in cell growth and the retinoic acid pathway
17. PML, a growth suppressor disrupted in acute promyelocytic leukemia
18. PML induces a novel caspase-independent death process
19. PML is essential for multiple apoptotic pathways
20. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
21. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukaemia cells
22. Structure, organisation and dynamics of PML nuclear bodies
23. A decade of molecular biology of retinoic add receptors
24. The pathogenesis of acute promyelocytic leukaemia: Evaluation of the role of molecular diagnosis and monitoring in the management of the disease
25. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications
26. Seed versus soil: The importance of the target cell for transgenic models of human leukemias
27. A bcr-3 isoform of RARα-PML potentiates the development of PML-RARα-driven acute promyelocytic leukemia
28. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor α clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia
29. In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes
30. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia
31. Rearrangements of the retinoic acid receptor alpha and promyelocytic zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukaemia
32. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-α locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia
33. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion
34. Fusion of retinoic acid receptor α to NuMA, the nuclear mitotic apparatus protein, by a variant transtocation in acute promyelocytic leukaemia
35. The signal transducer and activator of transcription STAT5b gene is a new partner of ratinoic acid receptor α in acute promyelocytic-like leukemia
36. Differentiation of t(5;17) variant acute promyelocytic leukemia blasts by all-trans retinoic acid
37. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17)
38. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia
39. Acute promyelocytic leukemia cases with nonreciprocal PML/RARα or RARα/PML fusion genes
40. Genomic structure of the human retinoic acid receptor-alpha 1 gene
41. Karyotyping human chromosomes by combinatorial multi-fluor FISH
42. High resolution multicelor-banding: A new technique for refined FISH analysis of human chromosomes
43. Molecular monitoring of the myl/retinoic acid receptor-α fusion gene in acute promyelocytic leukemia by polymerase chain reaction
44. Diagnosis of acute promyelocytic leukaemia by RT-PCR: Detection of PML-RARA and RARA-PML fusion transcripts
45. A PML/retinoic acid receptor alpha fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia
46. Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor
47. Genomic sequence structural organization, molecular evolution, and aberrant rearrangement of promyelocytic leukemia zinc finger gene
48. PML/RAR-alpha rearrangement in acute promyelocytic leukemia apparently lacking the t(15;17) translocation
49. Identification of DNA rearrangements at the retinoic acid receptor-α (RAR-α) locus in all patients with acute promyelocytic leukemia (APL) and mapping of APL breakpoints within the RAR-α second intron
50. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus
51. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: Structure-function relationship
52. Detection of normal and chimeric nucleophosmin in human cells
53. PML protein expression in hematopoietic and acute promyelocytic leukemia cells
54. A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies
55. Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: Immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia
56. Translocation of BCR to chromosome 9: A new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia
57. PML/RARα rearrangement in acute promyelocytic leukaemia with t(1;17) elucidated using fluorescence in situ hybridisation
58. Retinoic acid, but not arsenic trioxide, degrades the PLZF/RAR alpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient
59. Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient
60. Acute premyelocytic leukaemia with t(11; 17)(q23;q12-21) and a good initial response to prolonged ATRA and combination chemotherapy
61. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: A previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3
62. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the rote of maintenance therapy in newly diagnosed acute premyelocytic leukemia
63. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: A Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study
64. Postremission therapy for patients with AML in first CR in the AML 10 trial of the EORTC LCG and GIMEMA
65. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia
66. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in a non-Hodgkin's lymphoma
67. Unbalanced translocation t(5;17) in an atypical acute promyelocytic leukemia
68. Atypical response to all-trans retinoic acid in a der(5)t(5;17) acute promyelocytic leukemia
69. Leukemia initiated by PMLRARα: The PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable
70. Location of the BCR-ABL fusion gene in two cases of Ph-positive chronic myeloid leukemia
71. The nuclear topography of ABL, BCR, PML, and RARα genes: Evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation
72. RARα-PLZF is a critical determinant of the leukemic phenotype in APL
73. Cryptic insertion (15;17) in a case of acute promyelocytic leukemia detected by fluorescence in situ hybridization